Existing Home Sales Seen Down — Data Week Ahead
The following are median forecasts for this week's remaining U.S. data from a survey compiled by The Wall Street Journal.
Forecasts were last updated Monday afternoon.
DATE TIME RELEASE PERIOD CONSENSUS PREVIOUS Thursday 0830 Jobless Claims Apr 13 215K (19) 211K 0830 Phila Fed Mfg Survey Apr 2.5 (17) 3.2 1000 Existing Home Sales Mar 4.17M (24) 4.38M -- percent change Mar -4.8% +9.5% 1000 Leading Index Mar -0.1% (17) +0.1% (Figures in parentheses refer to number of economists surveyed.) Write to Donna Huneke at dataweekahead@wsj.com
(END) Dow Jones Newswires
April 17, 2024 10:14 ET (14:14 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure